Healthcare -
Biotechnology - NASDAQ - US
$ 33.5
1.73 %
$ 9.57 B
Market Cap
21.61
P/E
EXEL - OPERATING EXPENSES
Operating Expenses EXEL - Exelixis, Inc.
1.59 B
LAST VALUE
20.36%
2 YEAR CAGR
32.49%
5 YEAR CAGR
21.32%
10 YEAR CAGR